---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040642"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2026-08-28T21:02:54+00:00"
generated_at: "2026-08-28T21:04:17.492453+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SRX Global issues 3,579 Series C preferred shares in $2.86M debt-for-equity swap

## Summary
- Issued 3,579 Series C convertible preferred shares for $2,862,500, paid via assignment of CERO Therapeutics notes ($2,812,500 principal + $50,000 accrued interest).
- Series C converts at fixed $2.1888/share; alternate conversion at 95% of lowest VWAP after stockholder approval, 90% on triggering events.
- Company may redeem Series C at 125% of conversion amount; preferred ranks pari passu with Series A and B preferred.
- Registration rights agreement filed to register resale of underlying common shares and warrant shares.
- Transaction executed as unregistered offering under Section 4(a)(2)/Reg D; no cash proceeds received.

## SEC filing metadata
- accession: 0001493152-26-040642
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2026-08-28T21:02:54+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315226040642/0001493152-26-040642-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315226040642/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040642
- JSON: https://secwatch.observer/filing/0001493152-26-040642.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040642.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.